Kevin Schroeder
Podiatrist · Parkersburg, WVNPI 1073505533
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.4% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Smith+Nephew at 44.0% of the total. Reporting peaked in 2021 at $296 and has fallen 75.4% since, to $73 in 2025. That places this record below the midpoint for podiatrist clinicians in WV, where the typical reported total is $1,242.
Across 60 payments — averaging $20.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$532
- Organogenesis Inc.$233
- Stryker$206
- Misonix Inc$69
- AbbVie$42
- Bioventus LLC$25
- plus $103 from 6 others
What the payments were for
- Speaking & faculty fees$807%
- Food & beverage$1,13193%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 33 | $532 |
| Organogenesis Inc. | 9 | $233 |
| Stryker | 4 | $206 |
| Misonix Inc | 3 | $69 |
| AbbVie | 2 | $42 |
| Bioventus LLC | 1 | $25 |
| Trice Medical, Inc. | 1 | $23 |
| Convatec Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $16 |
| Reprise Biomedical, Inc. | 3 | $14 |
| Merck | 1 | $13 |
How this compares
$1,210 in reported general payments places this provider in the 45th percentile of 37 podiatrist providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 48 | $351 |
| Clindamycin Hcl | 39 | $239 |
| Gabapentin | 23 | $228 |
| Triamcinolone Acetonide | 15 | $167 |
| Ciprofloxacin Hcl | 22 | $140 |
| Levofloxacin | 25 | $118 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $85 |
| Doxycycline Hyclate | 16 | $84 |
| Silver Sulfadiazine | 13 | $68 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $46 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Parkersburg
- Barbara HageyParkersburg$862
- Bruce WinansParkersburg$449
- Donald HebbParkersburg$290
- Douglas DockeryPrinceton$11K
- Kirt MillerHuntington$6K
- Marian KavanaughWheeling$6K
- Marshal GwynnPrinceton$5K
- Joseph GoodwinWheeling$5K
- Jerry HadrychFairmont$5K
- Jessica MullinsCharleston$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.